Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$524M |
| 2 |
Meta Platforms (Facebook)
META
|
+$458M |
| 3 |
Otis Worldwide
OTIS
|
+$345M |
| 4 |
T-Mobile US
TMUS
|
+$307M |
| 5 |
AbbVie
ABBV
|
+$280M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$878M |
| 2 |
RTN
Raytheon Company
RTN
|
+$537M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$435M |
| 4 |
Apple
AAPL
|
+$389M |
| 5 |
Accenture
ACN
|
+$216M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.72% |
| 2 | Healthcare | 14.52% |
| 3 | Financials | 12.98% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Communication Services | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CBIO
2826
Crescent Biopharma
CBIO
$552M
| $2.03M | ﹤0.01% |
5,394
+220
| +4% | +$62.3K |
|
|
SBBP
2827
DELISTED
Strongbridge Biopharma plc.
SBBP
| $2.03M | ﹤0.01% |
536,700
+4,606
| +0.9% | +$13.8K |
|
2828
Radiant Logistics
RLGT
$393M
| $2.02M | ﹤0.01% |
514,732
+3,573
| +0.7% | +$13.8K |
|
2829
Western New England Bancorp
WNEB
$263M
| $2.02M | ﹤0.01% |
349,094
+6,780
| +2% | +$37.6K |
|
2830
Fortress Biotech
FBIO
$91.7M
| $2.02M | ﹤0.01% |
50,265
+27,187
| +118% | +$1.01M |
|
|
SBBX
2831
DELISTED
SB One Bancorp Common Stock
SBBX
| $2.02M | ﹤0.01% |
102,491
+3,241
| +3% | +$56.2K |
|
2832
Telecom Argentina
TEO
$5.98B
| $2.02M | ﹤0.01% |
226,965
+3,305
| +1% | +$27.5K |
|
2833
Hawthorn Bancshares
HWBK
$271M
| $2.01M | ﹤0.01% |
114,805
+4,414
| +4% | +$69.6K |
|
2834
NI Holdings
NODK
$318M
| $2M | ﹤0.01% |
135,717
+8,399
| +7% | +$114K |
|
|
SLCT
2835
DELISTED
Select Bancorp, Inc.
SLCT
| $2M | ﹤0.01% |
245,904
+27,148
| +12% | +$205K |
|
|
ALSK
2836
DELISTED
Alaska Communications Systems
ALSK
| $2M | ﹤0.01% |
717,507
+342,551
| +91% | +$780K |
|
2837
Colliers International
CIGI
$5.08B
| $2M | ﹤0.01% |
34,773
-961
| -3% | -$51.4K |
|
|
BRT
2838
BRT Apartments
BRT
$282M
| $1.99M | ﹤0.01% |
184,232
-23,971
| -12% | -$244K |
|
2839
Methanex
MEOH
$4.2B
| $1.99M | ﹤0.01% |
104,121
-82,649
| -44% | -$1.37M |
|
2840
Pearson
PSO
$10.1B
| $1.99M | ﹤0.01% |
274,696
+43,154
| +19% | +$269K |
|
2841
iRadimed
IRMD
$1.17B
| $1.98M | ﹤0.01% |
85,522
+12,163
| +17% | +$261K |
|
|
SFE
2842
DELISTED
Safeguard Scientifics, Inc.
SFE
| $1.98M | ﹤0.01% |
283,060
+23,587
| +9% | +$149K |
|
2843
HBT Financial
HBT
$1.3B
| $1.98M | ﹤0.01% |
148,584
+12,589
| +9% | +$151K |
|
|
ESXB
2844
DELISTED
Community Bankers Trust Corporation
ESXB
| $1.98M | ﹤0.01% |
360,036
+13,600
| +4% | +$71K |
|
2845
Clearfield
CLFD
$436M
| $1.98M | ﹤0.01% |
141,601
+5,364
| +4% | +$69.5K |
|
2846
Minerva Neurosciences
NERV
$185M
| $1.97M | ﹤0.01% |
68,289
+6,902
| +11% | +$405K |
|
2847
Riverview Bancorp
RVSB
$108M
| $1.97M | ﹤0.01% |
348,514
+9,185
| +3% | +$46.8K |
|
|
CNR
2848
Core Natural Resources Inc
CNR
$4.05B
| $1.97M | ﹤0.01% |
388,217
-575
| -0.1% | -$3.59K |
|
|
HBMD
2849
DELISTED
Howard Bancorp, Inc. Common Stock
HBMD
| $1.97M | ﹤0.01% |
185,156
+1,392
| +0.8% | +$14.2K |
|
2850
Richmond Mutual Bancorp
RMBI
$252M
| $1.97M | ﹤0.01% |
174,847
+3,333
| +2% | +$35.2K |
|
Similar funds
Geode Capital Management's Q2 2020 Portfolio in Review
As of Q2 2020, Geode Capital Management held 4,219 positions worth $467B, up 22% from $384B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q2 2020 filing shows 118 new, 2,550 increased, 1,055 reduced and 119 closed positions. Its largest new stake was Otis Worldwide: 6,650,358 shares worth $377M. The largest sale was Allergan plc, an estimated $878M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q2 2020 buy was Otis Worldwide: 6,650,358 shares worth $377M.
- Geode Capital Management added most to Amazon in Q2 2020, an estimated $524M increase.
- Geode Capital Management's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $435M.
- Geode Capital Management fully exited Allergan plc in Q2 2020, selling an estimated $878M.
- Geode Capital Management's ten largest holdings make up 23% of its $467B portfolio in Q2 2020.
- Geode Capital Management opened 118 new positions and closed 119 in Q2 2020.
- Geode Capital Management's portfolio value rose 22% quarter-over-quarter to $467B.
Based on Geode Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.